{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:23:34Z","timestamp":1772252614973,"version":"3.50.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circ Cardiovasc Genet"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec>\n            <jats:title>Background\u2014<\/jats:title>\n            <jats:p>\n              To test the association of a recently reported variant in the creatine kinase (CK) muscle gene,\n              <jats:italic>CKM<\/jats:italic>\n              Glu83Gly (rs11559024) with constitutive creatine phosphokinase (CK) levels, CK variation, and inducibility. Given the diagnostic importance of CK in determining muscle damage, we tested the association of the variant with myalgia.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and Results\u2014<\/jats:title>\n            <jats:p>\n              Meta-analysis between longitudinal cohort GoDARTS (Genetics of Diabetes Audit and Research, Tayside Scotland), minor allele frequency (=0.02), and randomized clinical trial (JUPITER [Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin], minor allele frequency=0.018) was used to replicate the association with baseline CK measures. GoDARTS was used to study the relationship with CK variability. Myalgia was studied in JUPITER trial participants. Baseline and SDs of CK were on average 18% (\n              <jats:italic>P<\/jats:italic>\n              value=6\u00d710\n              <jats:sup>\u2212<\/jats:sup>\n              <jats:sup>63<\/jats:sup>\n              ) and 24% (\n              <jats:italic>P<\/jats:italic>\n              value=2\u00d710\n              <jats:sup>\u22125<\/jats:sup>\n              ) lower for carriers of the variant, respectively. The variant was not associated with myalgia (odds ratio, 0.84; 95% confidence interval, 0.52\u20131.38).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions\u2014<\/jats:title>\n            <jats:p>This study highlights that a genetic factor known to be associated with constitutive CK levels is also associated with CK variability and inducibility. This is discussed in the context of evidence to suggest that the variant has an impact on inducibility of CK by trauma through a previously reported case of a homozygous carrier. However, the lack of association between the variant and myalgia suggests that it cannot reliably be used as a biomarker for muscle symptoms.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/circgenetics.117.001737","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T00:55:17Z","timestamp":1502240117000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["<i>CKM<\/i>\n            Glu83Gly Is Associated With Blunted Creatine Kinase Variation, but Not With Myalgia"],"prefix":"10.1161","volume":"10","author":[{"given":"Moneeza Kalhan","family":"Siddiqui","sequence":"first","affiliation":[{"name":"From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abirami","family":"Veluchamy","sequence":"additional","affiliation":[{"name":"From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrielle","family":"Maroteau","sequence":"additional","affiliation":[{"name":"From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Tavendale","sequence":"additional","affiliation":[{"name":"From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Carr","sequence":"additional","affiliation":[{"name":"From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewan","family":"Pearson","sequence":"additional","affiliation":[{"name":"From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Colhoun","sequence":"additional","affiliation":[{"name":"From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Morris","sequence":"additional","affiliation":[{"name":"From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"George","sequence":"additional","affiliation":[{"name":"From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Doney","sequence":"additional","affiliation":[{"name":"From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munir","family":"Pirmohamed","sequence":"additional","affiliation":[{"name":"From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Alfirevic","sequence":"additional","affiliation":[{"name":"From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia","family":"Wadelius","sequence":"additional","affiliation":[{"name":"From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke H.","family":"Maitland van der Zee","sequence":"additional","affiliation":[{"name":"From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"Ridker","sequence":"additional","affiliation":[{"name":"From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel I.","family":"Chasman","sequence":"additional","affiliation":[{"name":"From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin N.A.","family":"Palmer","sequence":"additional","affiliation":[{"name":"From the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (M.K.S., A.V., C.M., R.T., F.C., E.P., J.G., A.D., C.N.A.P.); Centre for Genomic and Experimental Medicine (H.C.) and Usher Institute of Population Health Sciences and Informatics (A.D.M.), University of Edinburgh, United Kingdom; Institute of Translational Medicine, University of Liverpool, United Kingdom (M..."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","unstructured":"National Center of Biotechnology Information. Creatine Kinase [Homo sapiens] [Internet]. http:\/\/www.ncbi.nlm.nih.gov\/protein\/AAA96609.1. Accessed January 28 2016."},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2000.80.3.1107"},{"key":"e_1_3_4_4_2","volume-title":"Clinical Methods: The History, Physical, and Laboratory Examinations","author":"Cabaniss C.","year":"1990","unstructured":"Cabaniss C.Clinical Methods: The History, Physical, and Laboratory Examinations. Boston, MA: Butterworths; 1990."},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10572"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2016.268425"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.02.006"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00001-08"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0801327"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.29074\/ascls.23.3.134","article-title":"A tale of two biomarkers: the use of troponin and CK-MB in contemporary practice.","volume":"23","author":"Saenger AK","year":"2010","unstructured":"Saenger AK. A tale of two biomarkers: the use of troponin and CK-MB in contemporary practice. Clin Lab Sci. 2010;23:134\u2013140.","journal-title":"Clin Lab Sci"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01706-5"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00804-4"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1373\/49.8.1331"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/33.3.231"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100670070049"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.5694\/j.1326-5377.1972.tb47015.x","article-title":"A review of the value of creatine phosphokinase estimations in clinical medicine.","volume":"1","author":"King JO","year":"1972","unstructured":"King JO, Zapf P. A review of the value of creatine phosphokinase estimations in clinical medicine. Med J Aust. 1972;1:699\u2013703.","journal-title":"Med J Aust"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-006-0701-0"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-5-9"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv043"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2014.03.003"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/07435800500371706"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-008-0651-y"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.584490"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.113.000395"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.111.961144"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807646"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.09.082"},{"key":"e_1_3_4_28_2","unstructured":"RStudio Team. RStudio: Integrated Development Environment for R. 2015. http:\/\/www.rstudio.com\/. Accessed June 7 2016."},{"key":"e_1_3_4_29_2","unstructured":"R Development Core Team. R: A Language and Environment for Statistical Computing. 2008. http:\/\/www.r-project.org. Accessed June 7 2016."},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v036.i03"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2009.38"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcv215"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1086\/511638"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature11632"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2015.06.002"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60716-8"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/2047487315602861"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.121"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2015.1039980"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-7-200210010-00009"},{"key":"e_1_3_4_41_2","first-page":"854","article-title":"Creatine kinase levels and statin-induced myopathy.","volume":"67","author":"Sadovsky R","year":"2003","unstructured":"Sadovsky R. Creatine kinase levels and statin-induced myopathy. Am Fam Physician. 2003;67:854\u2013855. http:\/\/www.aafp.org\/afp\/2003\/0215\/p854.html. Accessed July 17, 2017.","journal-title":"Am Fam Physician"}],"container-title":["Circulation: Cardiovascular Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCGENETICS.117.001737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T01:34:50Z","timestamp":1715564090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCGENETICS.117.001737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1161\/CIRCGENETICS.117.001737"],"URL":"https:\/\/doi.org\/10.1161\/circgenetics.117.001737","relation":{},"ISSN":["1942-325X","1942-3268"],"issn-type":[{"value":"1942-325X","type":"print"},{"value":"1942-3268","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8]]},"article-number":"e001737"}}